Press "Enter" to skip to content

Molecular Neurodegeneration where the publication would be the official open access journal of AHAF.

Having MN as the official journal of AHAF will help us to do that. The open-access model strives to conquer barriers by traditional scientific publications that restrict distribution to those who can afford the fees for digital access . The content released in MN will be free and will not merely help patients and healthcare providers stay up to date with the latest progress, but may also enable scientists to rapidly communicate their important study to the global community. We are very excited about this partnership, says AHAF’s Vice President of Scientific Affairs, Man Eakin, Ph.D., Having Molecular Neurodegeneration simply because the state journal is important to AHAF’s long-time history of support for ground-breaking aging research.This content was reprinted from with permission from the Henry J. Kaiser Family members Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family members Foundation, a nonpartisan health care policy research business unaffiliated with Kaiser Permanente. Â.

Juan Valle, M.D., Harpreet Wasan, M.D., Daniel H. Palmer, M.D., Ph.D., David Cunningham, M.D., Alan Anthoney, M.D., Anthony Maraveyas, M.D., Ph.D., Srinivasan Madhusudan, M.D., Ph.D., Tim Iveson, M.D., Sharon Hughes, B.Sc., Stephen P. Pereira, M.D., Ph.D., Michael Roughton, M.Sc., and John Bridgewater, M.D., Ph.D.